$LLY
Eli Lilly & Co.
XNYS•Health Care•Pharmaceutical Preparations
$1143.60
▼-0.54%-$6.25
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is LLY down today? It is at $1143.60 (-0.54%), and our scanner flagged it 101 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LLY spikes, and full due diligence on LLY — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LLY 101 times in the last 30 days. Create a free account to track $LLY, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LLY from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LLY today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystELI LILLY & Co: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 22, 2026 · 12 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Alvarez Ralph Director | Acquired (grant/award) | +11 | added <0.1% | 56K | $13K at $1164.89 | Sep 21, 26 |
Fyrwald J Erik Director | Acquired (grant/award) | +9 | added <0.1% | 76K | $10K at $1164.89 | Sep 21, 26 |
Luciano Juan R Director | Acquired (grant/award) | +14 | added <0.1% | 17K | $16K at $1164.89 | Sep 21, 26 |
Sulzberger Gabrielle Director | Acquired (grant/award) | +4 | added 0.1% | 3K | $5K at $1164.89 | Sep 21, 26 |
Seymour Melissa Officer | Sold (automatic/other) | -12 | sold 1.1% | 1K | n/a | Sep 9, 26 |
Dozier Eric Officer | Sold (automatic/other) | -216 | sold 1.5% | 14K | n/a | Sep 2, 26 |
Hernandez Edgardo Officer | Sold (automatic/other) | -13 | sold <0.1% | 46K | n/a | Sep 2, 26 |
Jonsson Patrik Officer | Sold (automatic/other) | -7K | sold 11% | 54K | $7.6M at $1175.10 | Aug 17, 26 |
Alvarez Ralph Director | Acquired (grant/award) | +10 | added <0.1% | 56K | $12K at $1183.16 | Aug 17, 26 |
Fyrwald J Erik Director | Acquired (grant/award) | +8 | added <0.1% | 75K | $9K at $1183.16 | Aug 17, 26 |
Luciano Juan R Director | Acquired (grant/award) | +13 | added <0.1% | 17K | $15K at $1183.16 | Aug 17, 26 |
Sulzberger Gabrielle Director | Acquired (grant/award) | +4 | added 0.1% | 3K | $5K at $1183.16 | Aug 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Curated groups LLY belongs to. Tap one to see every member with today's move and why the group is moving.
Here is the latest on LLY from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LLY today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LLY last traded at $1143.60, down 0.54% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Eli Lilly & Co. (LLY) is next expected to report earnings on Thursday, October 29, 2026 (before open), about 25 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. LLY currently has a dividend yield of about 0.61% ($6.92 per share per year). Dividend figures can change; this is not investment advice.
The LLY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LLY 101 times in the last 30 days.
LLY (Eli Lilly & Co.) trades on XNYS, with a market cap of about $1.02T in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LLY for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LLY discussion
Sign in to ask a question or join the discussion.